PULMICORT FLEXHALER (budesonide) by Viatris is corticosteroid hormone receptor agonists [moa]. First approved in 2006.
Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
PULMICORT FLEXHALER is a metered-dose powder inhaler containing budesonide, a corticosteroid that acts as a hormone receptor agonist to reduce airway inflammation. It is used to treat asthma and COPD by delivering anti-inflammatory medication directly to the lungs. Budesonide suppresses local immune responses in the respiratory tract, reducing symptoms and exacerbations.
Product approaching loss of exclusivity with 101K annual claims indicates stable but mature market positioning; commercial team focus shifting toward lifecycle management and managed care negotiations.
Corticosteroid Hormone Receptor Agonists
Corticosteroid
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
QUARTZ: Comparative Effectiveness of Switching From Albuterol to Albuterol/Budesonide Versus Adding Low-dose ICS or LTRA to Albuterol
A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
Worked on PULMICORT FLEXHALER at Viatris? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on PULMICORT FLEXHALER offers 350 linked career opportunities spanning commercial field roles, market access strategy, and regulatory functions. This LOE-stage product provides exposure to managed care negotiations, generic defense strategies, and lifecycle management—critical skillsets for mid-career advancement in specialty pharma.
350 open roles linked to this drug